OUTCOMES OF PRO RE NATA VERSUS TREAT-AND-EXTEND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS FOR MYOPIC MACULAR NEOVASCULARIZATION IN MULTIETHNIC PATIENTS IN THE UNITED STATES
Comparing myopic MNV treatment regimens, anti-VEGF injections with PRN, TES, or TEM are effective for myopic MNV and have comparable visual outcomes. Because PRN provides favorable outcomes with fewer injections, it should be the first-line approach. However, a treat-and-extend approach with TES and TEM may be an option given individual patient factors.
Authors
- Mirataollah Salabati (ORCID: https://orcid.org/0000-0002-8654-2876)
- Mallory E. Bowers (ORCID: https://orcid.org/0000-0003-1618-1881)
- Jason Hsu (ORCID: https://orcid.org/0000-0002-2761-4219)
- James P. Dunn
- Bita Momenaei (ORCID: https://orcid.org/0000-0002-5435-7369)
- Shreya Swaminathan (ORCID: https://orcid.org/0000-0001-9730-1106)
- Raziyeh Mahmoudzadeh (ORCID: https://orcid.org/0000-0002-5818-9083)
- Taku Wakabayashi (ORCID: https://orcid.org/0000-0003-2640-6079)
- Robert M. Abishek
Institutions
- Thomas Jefferson University (US)
- Wills Eye Hospital (US)
Publication Details
- Journal
- Retina
- Published
- 2024-08-23
- DOI
- https://doi.org/10.1097/iae.0000000000004256
- Citations
- 2
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.08